Atlas Trials

Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg

Clinical trial NCT05888766 · UNKNOWN

Trial details

NCT number
NCT05888766
Sponsor
University of Roma La Sapienza
Status
UNKNOWN
Study type
OBSERVATIONAL
Migraine Disorders
Start date
2023-07-01
Primary completion
2024-07-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.